These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35660688)

  • 21. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
    Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
    J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.
    Veldman C; Feliciani C
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):313-20. PubMed ID: 18097775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemphigus Vulgaris Presenting as Chronic Vulvovaginal Erosions: The Importance of Autoantibody Testing: A Case Report.
    Davis SA; Davis LS
    J Reprod Med; 2016; 61(11-12):589-91. PubMed ID: 30226722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca
    Chernyavsky A; Patel KG; Grando SA
    Int Immunopharmacol; 2020 Mar; 80():106149. PubMed ID: 31958740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.
    Ohata C; Ishii N; Furumura M
    J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective.
    van der Wier G; Jonkman MF; Pas HH; Diercks GF
    Br J Dermatol; 2012 Dec; 167(6):1265-71. PubMed ID: 22835262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.
    Belloni-Fortina A; Faggion D; Pigozzi B; Peserico A; Bordignon M; Baldo V; Alaibac M
    Clin Dev Immunol; 2009; 2009():187864. PubMed ID: 20049340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies.
    Isogai R; Kawada A; Aragane Y; Amagai M; Tezuka T
    J Dermatol; 2004 May; 31(5):407-10. PubMed ID: 15187309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Juvenile pemphigus vulgaris].
    Janisson-Dargaud D; Reguiaï Z; Perceau G; Eschard C; Bernard P
    Ann Dermatol Venereol; 2008 Dec; 135(12):843-7. PubMed ID: 19084695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemphigus vulgaris localized to the nose and cheeks.
    Baykal C; Azizlerli G; Thoma-Uszynski S; Hertl M
    J Am Acad Dermatol; 2002 Dec; 47(6):875-80. PubMed ID: 12451372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.
    Lee HE; Berkowitz P; Jolly PS; Diaz LA; Chua MP; Rubenstein DS
    J Biol Chem; 2009 May; 284(18):12524-32. PubMed ID: 19270308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
    Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
    Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid transition from pemphigus vulgaris to pemphigus foliaceus.
    Ito T; Moriuchi R; Kikuchi K; Shimizu S
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):455-7. PubMed ID: 25376758
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1.
    Yoshifuku A; Fujii K; Kawahira H; Katsue H; Baba A; Higashi Y; Aoyama Y; Kanekura T
    Indian J Dermatol; 2016; 61(4):427-9. PubMed ID: 27512189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunolocalization of desmoglein I ("band 3" polypeptide) on acantholytic cells in pemphigus vulgaris, Darier's disease, and Hailey-Hailey's disease.
    Setoyama M; Hashimoto K; Tashiro M
    J Dermatol; 1991 Sep; 18(9):500-5. PubMed ID: 1787220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus.
    Kasperkiewicz M; Ellebrecht CT; Takahashi H; Yamagami J; Zillikens D; Payne AS; Amagai M
    Nat Rev Dis Primers; 2017 May; 3():17026. PubMed ID: 28492232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
    Brod C; Fierlbeck G; Metzler G; Sönnichsen K; Röcken M; Schaller M
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):280-2. PubMed ID: 16370478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.